1. Home
  2. GNPX vs GVH Comparison

GNPX vs GVH Comparison

Compare GNPX & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$2.02

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$3.07

Market Cap

6.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNPX
GVH
Founded
2009
2016
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.8M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
GNPX
GVH
Price
$2.02
$3.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$80.00
AVG Volume (30 Days)
274.8K
50.9K
Earning Date
11-14-2025
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
11.95
Revenue
N/A
$21,878,867.00
Revenue This Year
N/A
$141,706.20
Revenue Next Year
N/A
$3.35
P/E Ratio
N/A
$0.25
Revenue Growth
N/A
24.52
52 Week Low
$1.99
$2.95
52 Week High
$55.00
$364.00

Technical Indicators

Market Signals
Indicator
GNPX
GVH
Relative Strength Index (RSI) 33.69 36.42
Support Level $2.51 $2.95
Resistance Level $3.68 $4.03
Average True Range (ATR) 0.29 0.30
MACD -0.09 -0.01
Stochastic Oscillator 1.18 8.94

Price Performance

Historical Comparison
GNPX
GVH

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

Share on Social Networks: